Making The Case For Responsible Science For A Safe Environment 19/11/2010 by Intellectual Property Watch Leave a Comment Innovation or “jugaad” has always driven the Indian economy. However, the last decade has been witness to an emerging paradigm shift to high-quality value-added innovation, writes industry lawyer Sunita K. Sreedharan.
Global Copyright Reform — A View From The South In Response To Lessig 12/11/2010 by Intellectual Property Watch 7 Comments “Given that global copyright rules have acquired such a pervasive impact in many facets of our lives, their reform needs to take place through an open, inclusive and participatory consultation process where ‘all of us’ have a say,” writes Ahmed Abdel Latif.
A Tale Of A Visually Impaired Reader 11/11/2010 by Intellectual Property Watch 1 Comment I’d like to introduce myself and put my personal experience in the hands of all concerned parties and people, hoping that this will help to give a better comprehension (explain) about the situation of blind people and to help reach an international treaty that will facilitate access to knowledge for people with visual impairments, writes law professor Mohammed Mohsin Abrahim El Nagaar of Alexandria University.
November Edition Of IP-Watch Monthly Reporter Now Available 09/11/2010 by Intellectual Property Watch, Intellectual Property Watch Leave a Comment The Intellectual Property Watch Monthly Edition features top news on international IP policymaking, the latest on who is coming and going in the international IP community, news briefs and more. The November edition is now available for subscribers at: http://www.ip-watch.org/user/newsletter.
Sharing US Drug Patents with Neglected Patients: A Scientist’s View 05/11/2010 by Intellectual Property Watch 1 Comment “Instead of re-hashing old debates about patents, patients and profits, forward-looking pharmaceutical executives should consider new ways of ensuring that medicines reach all patients who need them,” writes John Erickson, one of the researchers who discovered the HIV medicine recently licensed by the National Institutes of Health to the Medicines Patent Pool.
A Primer On Spotting IP Issues Associated with Social Media Websites and Content 30/10/2010 by Intellectual Property Watch Leave a Comment Most businesspeople and generalists understand that social media can be an important but risky part of doing business. This article seeks to identify how to spot potential intellectual property law issues associated with social media websites and content that can arise for a company.
Big Pharma Stranglehold: Thwarting India As Independent Maker Of Blockbuster HIV Drugs? 28/10/2010 by Intellectual Property Watch 2 Comments Daniele Dionisio writes: The current break-through of multinational drug corporations in India couples with the protectionist policies pursued by the US and EU and with India’s obligations as a WTO member. Taken together, these realities mean a heavy threat to India’s freedom as independent provider of lifesaving, affordable and state-of-the-art antiretroviral medicines to the resource-limited countries.
Flexibility In Government Procurement Needed For Developing Countries 22/10/2010 by Intellectual Property Watch 3 Comments If public procurement for innovation is to be seen as part of developing countries’ industrial-policy portfolio, a recent paper argues accession to the GPA would not help, and advises against it, writes Riaz K. Tayob.
October Edition Of IP-Watch Monthly Reporter Now Available 12/10/2010 by Intellectual Property Watch, Intellectual Property Watch Leave a Comment The Intellectual Property Watch Monthly Edition features top news on international IP policymaking, the latest on who is coming and going in the international IP community, news briefs and more. The October edition is now available for subscribers at: http://www.ip-watch.org/user/newsletter.
A Rights-Poor Protocol For Biodiversity Access & Benefit-Sharing 08/10/2010 by Intellectual Property Watch 2 Comments A leading indigenous negotiator for a UN protocol on biodiversity access and benefit sharing says the process will likely yield a highly diluted, rights-poor protocol and that Indigenous Peoples’ negotiating leverage is slipping.